Focus: Biolase is a public biotechnology company specializing in dental laser systems and therapies for oral health applications. The company operates in a niche but established market focused on dental clinical solutions.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
16 added, 15 removed. Backfill posture.
Biolase represents a stable niche play for candidates seeking dental/oral health biotech experience, but current zero hiring and nascent pipeline suggest limited near-term career acceleration opportunities.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship product targeting halitosis treatment through laser therapy technology.
Help build intelligence for Biolase
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Biolase's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company